Eris Lifesciences Limited (NSE: ERIS), ISIN INE406M01024 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
ERIS last traded at ₹1373.35 (-3.77%), with a 52-week range of ₹1237.90 to ₹1887.65 (as of 30 Jul 2026).
Shareholding as of Jun 2026: promoters 54.14%, FIIs 5.75%, DIIs 20.72%, mutual funds 18.88%.
EquiSense Score (ECS): 72/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.